Broad spectruma antagonists and vaccines directed against...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/315 (2006.01) A61K 39/02 (2006.01) A61K 39/085 (2006.01) C07K 14/31 (2006.01) A61K 38/11 (2006.01)

Patent

CA 2389911

The invention relates to peptides comprising an amino acid sequence homologous to the amino sequence of a fragment of a pyrogenic exotoxin, and functional derivatives of said peptides, capable of eliciting protective immunity against toxic shock induced by a pyrogenic exotoxin or by a mixture of pyrogenic exotoxins and of protecting against toxic shock induced by pyrogenic exotoxins. The invention also relates to broad spectrum pharmaceutical compositions and methods for the treatment, protection against or short term prophylaxis of toxin-mediated activation of T cells and toxic shock induced by a pyrogenic exotoxin or by a mixture of pyrogenic exotoxins, comprising at least one peptide of the invention or derivative thereof, and to broad spectrum vaccines for conferring long term immunity against toxic shock induced by at least one pyrogenic exotoxin are provided. The invention also relates to composition and method for the treatment of incapacitation induced by at least one pyrogenic exotoxin.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Broad spectruma antagonists and vaccines directed against... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Broad spectruma antagonists and vaccines directed against..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Broad spectruma antagonists and vaccines directed against... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1967236

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.